lifestyle.forkstofeet.com

ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310

Written by

ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310 – NEWSnet – News… as it used to be

More Press Releases

April 24, 2026

The Sterling Group Foundation Fund Acquires Scruggs, a Provider of Municipal Water Infrastructure Solutions

April 24, 2026

Dr. Alonso Martin Brings a Data-Driven Perspective on Longevity and Biological Age to The Marty Davis Show

April 24, 2026

United for Human Rights Participates in NAACP Prayer Breakfast in Sacramento

April 24, 2026

Federal Contractor Minimum Wage Update Takes Effect in 2026